Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Cytometry. Part B, Clinical Cytometry|June 15, 2019
A High-Sensitivity 10-Color Flow Cytometric Minimal Residual Disease Assay in B-Lymphoblastic Leukemia/Lymphoma Can Easily Achieve the Sensitivity of 2-in-106 and Is Superior to Standard Minimal Residual Disease Assay: A Study of 622 PatientsPrashant R Tembhare, Papagudi G Subramanian Pg, Sitaram Ghogale, et al.
British Journal of Haematology|December 15, 2023
Treatment and follow-up of children with chronic myeloid leukaemia in chronic phase (CML-CP) in the tyrosine kinase inhibitor (TKI) era-Two decades of experience from the Tata Memorial Hospital paediatric CML (pCML) cohortNirmalya Roy Moulik, Swaminathan Keerthivasagam, Ankita Pandey, et al.
The Lancet Regional Health. Southeast Asia|June 9, 2025
Risk stratified treatment for childhood acute lymphoblastic leukaemia: a multicentre observational study from IndiaManash Pratim Gogoi, Parag Das, Nandana Das, et al.
The Lancet Regional Health. Southeast Asia|July 15, 2026
Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016-2022)Parag Das, Nandana Das, Gaurav Narula, et al.
JCO Global Oncology|February 29, 2024
Epilepsia Partialis Continua as a Sequelae of Measles Infection in Children With Hematolymphoid MalignanciesSudivya Sharma, Chetan Dhamne, Shilpushp Bhosale, et al.
British Journal of Haematology|September 3, 2021
Mimics and artefacts of measurable residual disease in a highly sensitive multicolour flow cytometry assay for B-lymphoblastic leukaemia/lymphoma: critical consideration for analysis of measurable residual diseaseGaurav Chatterjee, Harshini Sriram, Sitaram Ghogale, et al.
European Journal of Haematology|September 14, 2023
15-color highly sensitive flow cytometry assay for post anti-CD19 targeted therapy (anti-CD19-CAR-T and blinatumomab) measurable residual disease assessment in B-lymphoblastic leukemia/lymphoma: Real-world applicability and challengesGaurav Chatterjee, Priyanka Dhende, Simpy Raj, et al.
Indian Journal of Pathology & Microbiology|March 24, 2018
Applicability of 2008 World Health Organization classification system of hematolymphoid neoplasms: Learning experiencesSushil Modkharkar, Pooja Navale, Pratibha Kadam Amare, et al.
Leukemia & Lymphoma|March 22, 2016
Characteristics of BCR-ABL kinase domain mutations in chronic myeloid leukemia from India: not just missense mutations but insertions and deletions are also associated with TKI resistanceNikhil Patkar, Kiran Ghodke, Swapnali Joshi, et al.
Leukemia & Lymphoma|August 8, 2020
Machine learning derived genomics driven prognostication for acute myeloid leukemia with RUNX1-RUNX1T1Anam Fatima Shaikh, Chinmayee Kakirde, Chetan Dhamne, et al.
Pageof 8